Palindrome Technologies Designated Testing Facility for IEEE Medical Device Cybersecurity Certification Program

PRINCETON, N.J., Feb. 12, 2025 /PRNewswire/ -- Palindrome Technologies has been recognized as an official testing facility for the IEEE Medical Device Cybersecurity Certification Program, positioning the company at the forefront of medical device security. This certification program, launched in 2023 by the IEEE 2621™ Conformity Assessment Committee (CAC), offers a comprehensive evaluation process tailored specifically for medical devices in an increasingly connected healthcare landscape.

As an IEEE-designated security testing lab, Palindrome Technologies will play a crucial role in:

• Helping medical device vendors demonstrate security assurance and confidence in protecting consumer privacy
• Assisting vendors with enhancing their cybersecurity hygiene process for product development
• Ensuring device compliance with the IEEE 2621^TM Medical Device Cybersecurity specifications to demonstrate due diligence
• Enhancing vendor reputation and competitive advantage
• Elevating consumer trust and confidence

"We are proud to be recognized by IEEE for this critical certification program, as it will pave the way for greater vendor due-diligence of medical devices and help increase consumer trust and confidence," said Peter Thermos, CEO of Palindrome Technologies. "Our 20+ year track record and expertise in cybersecurity uniquely positions us to help medical device manufacturers ensure the security and compliance of their products."

"Palindrome's Symmetric Defense philosophy defines a holistic approach, based on in-depth and zero-trust principles to address security challenges, making us an ideal partner for medical device manufacturers seeking to navigate the complex landscape of cybersecurity regulations and best practices."

IEEE Medical Device Cybersecurity Certification Program: Addressing Risks and Expediting Approvals

The IEEE Medical Device Cybersecurity Certification Program aims to address cybersecurity risks in medical devices that capture and manage user biodata and impact quality of life. By submitting medical devices for IEEE 2621 certification, manufacturers can demonstrate conformity with an international standard, potentially expediting the approval process by regulatory bodies.

"The IEEE Standards Association offers a trusted platform to help expert technical communities make significant impacts on a large scale," said Ravi Subramaniam, Senior Director, IEEE Standards Association. "The IEEE Medical Device Cybersecurity Certification Program is a perfect example of that, providing a standards-based pathway for medical device manufacturers to meet global regulatory requirements, resulting in safer, compliant products for users. We're pleased to welcome Palindrome Technologies as an IEEE recognized testing facility under this program."

Palindrome Technologies encourages medical device manufacturers to proactively seek certification through this program that not only meets FDA submission criteria but also helps differentiate products in the marketplace. Certified devices will be included in the IEEE Medical Device Registry, providing additional visibility and credibility. 

For more information about Palindrome Technologies' services for the IEEE Medical Device Cybersecurity Certification Program, please visit the Palindrome website.

About Palindrome Technologies:

Since 2005, Palindrome Technologies has been a trusted cybersecurity partner to Fortune 500 companies and growing organizations that want to engineer cyber resilience in emerging threat environments. With a focus on excellence, curiosity, and integrity, Palindrome helps clients defend against cyberattacks across all attack surfaces, including hardware, software, network-to-cloud, people, and emerging technologies.

CONTACT:
Jennis Thomas
[email protected]

SOURCE Palindrome Technologies